Literature DB >> 9189136

False-positive FDG-PET imaging of the thymus of a child with Hodgkin's disease.

M E Weinblatt1, I Zanzi, A Belakhlef, B Babchyck, J Kochen.   

Abstract

During the evaluation of a child who had completed treatment for Hodgkin's disease, a PET study strongly suggested recurrent disease in the mediastinum. Biopsies were obtained and revealed normal thymic tissue only, with no evidence of recurrent disease. The ongoing difficulty in establishing accurate disease status in patients treated for Hodgkin's disease is discussed, along with recommendations for treating pediatric patient populations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9189136

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

Review 1.  Positron emission tomography and gallium metabolic imaging in lymphoma.

Authors:  B Coiffier
Journal:  Curr Oncol Rep       Date:  2001-05       Impact factor: 5.075

2.  F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas.

Authors:  Miguel Hernandez-Pampaloni; Amol Takalkar; Jian Q Yu; Hongming Zhuang; Abass Alavi
Journal:  Pediatr Radiol       Date:  2006-04-19

3.  Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.

Authors:  Craig H Moskowitz; Heiko Schöder; Julie Teruya-Feldstein; Camelia Sima; Alexia Iasonos; Carol S Portlock; David Straus; Ariela Noy; Maria L Palomba; Owen A O'Connor; Steven Horwitz; Sarah A Weaver; Jessica L Meikle; Daniel A Filippa; James F Caravelli; Paul A Hamlin; Andrew D Zelenetz
Journal:  J Clin Oncol       Date:  2010-03-08       Impact factor: 44.544

4.  18F-FDG PET in malignant lymphoma: significance of positive findings.

Authors:  Paolo Castellucci; PierLuigi Zinzani; Michael Pourdehnad; Lapo Alinari; Cristina Nanni; Mohsen Farsad; Giuseppe Battista; Monica Tani; Vittorio Stefoni; Romeo Canini; Nino Monetti; Domenico Rubello; Abass Alavi; Roberto Franchi; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-23       Impact factor: 9.236

5.  The clinical relevance of thymic fluorodeoxyglucose uptake in pediatric patients after chemotherapy.

Authors:  Tsuyoshi Kawano; Akiko Suzuki; Amane Ishida; Nobukazu Takahashi; Jin Lee; Yoshifumi Tayama; Takashi Oka; Shumpei Yokota; Tomio Inoue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-13       Impact factor: 9.236

6.  Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT.

Authors:  Linda Jorgov; Françoise Montravers; Sona Balogova; Christine Ragu; Hélène Pacquement; Thierry Leblanc; Samuel Abbou; Hubert Ducou-Lepointe; Judith Landman-Parker; Jean-Noёl Talbot
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-14       Impact factor: 9.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.